Cajeta, Rowena M.

HRN: 18-45-91  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2022
CEFUROXIME 1.5GM (VIAL)
12/17/2022
12/18/2022
IVT
1.5g
Q8 X 3 Doses
S/P Primary LTCS
Waiting Final Action 
12/17/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/17/2022
12/18/2022
IVT
500mg
Q8 X 3 Doses
S/P Primary LTCS
Waiting Final Action 
12/18/2022
CEFUROXIME 500MG (TAB)
12/18/2022
12/25/2022
PO
500
BID
Empiric Tx
Waiting Final Action 
12/18/2022
METRONIDAZOLE 500MG (TAB)
12/18/2022
12/25/2022
PO
500
BID
Empiric Tx
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: